Transient suppression of fibrinolytic potential during cytokine release syndrome after chimeric antigen receptor T-cell therapy in B-cell malignancies.

Kymriah (tisagenlecleucel-T) - Novartis

http://www.ncbi.nlm.nih.gov/pubmed/42790202

Akifumi Takaori-Kondo; Keiji Nogami; Makiko Yamasaki-Morita; Miki Nagao; Souichi Adachi; Takashi Ishihara; Tomoko Onishi; Yasuyuki Arai

Sep 26, 2026